全球遺傳疾病檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

基因疾病檢測市場預計將從 2025 年的 83.1 億美元成長到 2034 年的 179.4 億美元，2026 年至 2034 年的複合年成長率為 8.93%。

由於人們對遺傳疾病的認知不斷提高，以及對早期診斷重要性的日益重視，全球基因檢測市場正經歷快速成長。基因檢測有助於識別與遺傳疾病相關的基因突變，從而實現預防醫學和個人化治療方案。精準醫療的日益普及是推動市場擴張的主要因素。

基因定序技術的進步、檢測成本的降低以及面向消費者的基因檢測日益普及是推動市場成長的關鍵因素。醫療專業人員擴大建議對癌症、心血管疾病和罕見遺傳疾病等病症進行基因檢測。政府促進基因研究的措施也為市場成長提供了支持。

隨著人工智慧和巨量資料分析技術融入基因分析，預計未來市場將持續成長。新興地區醫療資源的普及和認知度的提高將進一步推動基因檢測的普及。隨著個人化醫療日益重要，基因檢測將在疾病預防和管理中發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球遺傳疾病檢測市場：依產品分類

• 市場分析、洞察與預測
• 遺傳性癌症檢測
• 遺傳性非癌症檢測

第5章 全球遺傳疾病檢測市場：依技術分類

• 市場分析、洞察與預測
• 細胞遺傳學
• 生物化學
• 分子檢測

第6章 全球遺傳疾病檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Myriad Genetics Inc
  • Invitae Corporation
  • IlluminaInc
  • NateraInc
  • Laboratory Corporation Of America Holdings
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Incorporated
  • CooperSurgical Inc
  • Agilent Technologies Inc
  • Thermo Fisher ScientificInc

The Hereditary Testing Market size is expected to reach USD 17.94 Billion in 2034 from USD 8.31 Billion (2025) growing at a CAGR of 8.93% during 2026-2034.

The global hereditary testing market is witnessing rapid growth due to increasing awareness of genetic disorders and the importance of early diagnosis. Hereditary testing helps identify genetic mutations associated with inherited diseases, enabling preventive healthcare and personalized treatment plans. The growing focus on precision medicine is a major driver of market expansion.

Key drivers include advancements in genetic sequencing technologies, declining costs of testing, and rising adoption of direct-to-consumer genetic tests. Healthcare providers are increasingly recommending hereditary testing for conditions such as cancer, cardiovascular diseases, and rare genetic disorders. Government initiatives promoting genetic research are also supporting market growth.

Looking ahead, the market is expected to expand with the integration of AI and big data analytics in genetic analysis. Increased accessibility and awareness in emerging regions will further boost adoption. As personalized healthcare becomes more prominent, hereditary testing will play a critical role in disease prevention and management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Hereditary Cancer Testing
• Hereditary Non-cancer Testing

By Technology

• Cytogenetic
• Biochemical
• Molecular Testing

COMPANIES PROFILED

• Myriad Genetics Inc, Invitae Corporation, Illumina, Inc, Natera, Inc, Laboratory Corporation of America Holdings, F HoffmannLa Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical Inc, Agilent Technologies Inc, Thermo Fisher Scientific, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEREDITARY TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Hereditary Cancer Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hereditary Non-cancer Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEREDITARY TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Cytogenetic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biochemical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Molecular Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEREDITARY TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Technology
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Technology
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Technology
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Technology
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Technology
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEREDITARY TESTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Myriad Genetics Inc
  • 8.2.2 Invitae Corporation
  • 8.2.3 IlluminaInc
  • 8.2.4 NateraInc
  • 8.2.5 Laboratory Corporation Of America Holdings
  • 8.2.6 F. Hoffmann-La Roche Ltd
  • 8.2.7 Quest Diagnostics Incorporated
  • 8.2.8 CooperSurgical Inc
  • 8.2.9 Agilent Technologies Inc
  • 8.2.10 Thermo Fisher ScientificInc